<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD00710000_1</Organism_ID>
  <Organism>E.coli</Organism>
  <Organism_Latin>Escherichia coli</Organism_Latin>
  <UniProt_ID>P0ABH7</UniProt_ID>
  <Seq_Length>427</Seq_Length>
  <Molecule_Weight>48015</Molecule_Weight>
  <KEGG_ID>ecj:Y75_p0700</KEGG_ID>
  <Orthology_ID>K01647</Orthology_ID>
  <EBI_ID>EBI-547808</EBI_ID>
  <Catalytic_Mechanism>Acetyl-CoA + H(2)O + oxaloacetate = citrate + CoA.</Catalytic_Mechanism>
  <Pfam_ID>PF00285:Citrate_synt</Pfam_ID>
  <Allosteric_Activator_Count>1</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>5</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>1</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Type II CS</Alias>
      <Alias>Type II Citrate Synthases</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.</Detail>
      <Keyword>Catalytic activity</Keyword>
      <Ontology_ID>GO:0003824</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with an identical protein or proteins.</Detail>
      <Keyword>Identical protein binding</Keyword>
      <Ontology_ID>GO:0042802</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.</Detail>
      <Keyword>Transferase activity</Keyword>
      <Ontology_ID>GO:0016740</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: acetyl-CoA + H2O + oxaloacetate = citrate + CoA, where the acetyl group is added to the si-face of oxaloacetate; acetyl-CoA thus provides the two carbon atoms of the pro-S carboxymethyl group.</Detail>
      <Keyword>Citrate (Si)-synthase activity</Keyword>
      <Ontology_ID>GO:0004108</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y, as carried out by individual cells.</Detail>
      <Keyword>Cellular carbohydrate metabolic process</Keyword>
      <Ontology_ID>GO:0044262</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A nearly universal metabolic pathway in which the acetyl group of acetyl coenzyme A is effectively oxidized to two CO2 and four pairs of electrons are transferred to coenzymes. The acetyl group combines with oxaloacetate to form citrate, which undergoes successive transformations to isocitrate, 2-oxoglutarate, succinyl-CoA, succinate, fumarate, malate, and oxaloacetate again, thus completing the cycle. In eukaryotes the tricarboxylic acid is confined to the mitochondria. See also glyoxylate cycle.</Detail>
      <Keyword>Tricarboxylic acid cycle</Keyword>
      <Ontology_ID>GO:0006099</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>283</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MADTKAKLTLNGDTAVELDVLKGTLGQDVIDIRTLGSKGVFTFDPGFTSTASCESKITFIDGDEGILLHRGFPIDQLATDSNYLEVCYILLNGEKPTQEQYDEFKTTVTRHTMIHEQITRLFHAFRRDSHPMAVMCGITGALAAFYHDSLDVNNPRHREIAAFRLLSKMPTMAAMCYKYSIGQPFVYPRNDLSYAGNFLNMMFSTPCEPYEVNPILERAMDRILILHADHEQNASTSTVRTAGSSGANPFACIAAGIASLWGPAHGGANEAALKMLEEISSVKHIPEFVRRAKDKNDSFRLMGFGHRVYKNYDPRATVMRETCHEVLKELGTKDDLLEVAMELENIALNDPYFIEKKLYPNVDFYSGIILKAMGIPSSMFTVIFAMARTVGWIAHWSEMHSDGMKIARPRQLYTGYEKRDFKSDIKR</Protein_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>gltA</Gene_Name>
    <Gene_Alias>gluT; icdB</Gene_Alias>
    <Gene_ID>12930947</Gene_ID>
    <Genbank_ACCN>NC_000913</Genbank_ACCN>
    <Protein_ACCN>NP_415248</Protein_ACCN>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/945323</Gene_URL>
    <EMBL_ID>EBESCG00000014792</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>P0ABH7</Uniprot_ID>
      <Gene_Name>gltA</Gene_Name>
      <EBI_ID>EBI-547808</EBI_ID>
      <PPI_EBI_URL>EBI-547808,EBI-547808</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
  </PPI_List>
  <PDB_List>
    <PDB>
      <PDB_Title>The F383A variant of type II Citrate Synthase complexed with NADH</PDB_Title>
      <PDB_ID>1NXG</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1NXG</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD06128001</ASD_Ligand>
      <PubMed_Title>Insights into the evolution of allosteric properties. The NADH binding site of hexameric type II citrate synthases.</PubMed_Title>
      <Author>Maurus R, et al.</Author>
      <Journal>Biochemistry. 2003 May 20;42(19):5555-65.</Journal>
      <PubMed_ID>12741811</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURAL DETERMINATION OF THE A50T:S279G:S280K:V281K:K282E:H283N VARIANT OF CITRATE SYNTHASE FROM E. COLI COMPLEXED with NADH</PDB_Title>
      <PDB_ID>4JAF</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4JAF</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD06128001</ASD_Ligand>
      <PubMed_Title>Enzyme-substrate complexes of allosteric citrate synthase: Evidence for a novel intermediate in substrate binding.</PubMed_Title>
      <Author>Duckworth, H.W., et al.</Author>
      <Journal>Biochim.Biophys.Acta(2013)1834:2546-2553</Journal>
      <PubMed_ID>23954305</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Three Dimensional Structure Analysis of the Type II Citrate Synthase from E.coli</PDB_Title>
      <PDB_ID>1K3P</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1K3P</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Comparative analysis of folding and substrate binding sites between regulated hexameric type II citrate synthases and unregulated dimeric type I enzymes.</PubMed_Title>
      <Author>Nguyen NT, et al.</Author>
      <Journal>Biochemistry. 2001 Nov 6;40(44):13177-87.</Journal>
      <PubMed_ID>11683626</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Three Dimensional Structure Analysis Of The R109L Variant of the Type II Citrate Synthase From E. Coli</PDB_Title>
      <PDB_ID>1OWC</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1OWC</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Probing the roles of key residues in the unique regulatory NADH binding site of type II citrate synthase of Escherichia coli.</PubMed_Title>
      <Author>Stokell DJ, et al.</Author>
      <Journal>J Biol Chem. 2003 Sep 12;278(37):35435-43.</Journal>
      <PubMed_ID>12824188</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>A Novel NADH Allosteric Regulator Site is Found on the Surface of the Hexameric Type II Phe383Ala Variant of Citrate Synthase</PDB_Title>
      <PDB_ID>1NXE</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1NXE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Insights into the evolution of allosteric properties. The NADH binding site of hexameric type II citrate synthases.</PubMed_Title>
      <Author>Maurus R, et al.</Author>
      <Journal>Biochemistry. 2003 May 20;42(19):5555-65.</Journal>
      <PubMed_ID>12741811</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Three Dimensional Structure Analysis Of The Variant R109L NADH Complex of Type II Citrate Synthase From E. Coli</PDB_Title>
      <PDB_ID>1OWB</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1OWB</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01720006</ASD_Ligand>
      <PubMed_Title>Probing the roles of key residues in the unique regulatory NADH binding site of type II citrate synthase of Escherichia coli.</PubMed_Title>
      <Author>Stokell DJ, et al.</Author>
      <Journal>J Biol Chem. 2003 Sep 12;278(37):35435-43.</Journal>
      <PubMed_ID>12824188</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko01230</Pathway_ID>
      <Pathway_Title>Biosynthesis of amino acids</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Overview</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko01210</Pathway_ID>
      <Pathway_Title>2-Oxocarboxylic acid metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Overview</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00630</Pathway_ID>
      <Pathway_Title>Glyoxylate and dicarboxylate metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Carbohydrate metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko01200</Pathway_ID>
      <Pathway_Title>Carbon metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Overview</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>All alpha proteins</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.b.cad.b.b.g.html</SCOP_URL>
    <CATH_Class>Mainly alpha</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1nxg</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Detail>site,190,Asn;site,183,Gln;site,109,Thr;site,110,Arg;site,112,Thr;site,207,Cys;site,113,Met;site,205,Thr;site,208,Glu;site,146,Tyr;site,168,Lys;site,115,His;site,181,Ile;site,164,Arg;site,160,Ile;site,107,Thr</Site_Detail>
      <Site_Reference>Maurus R, et al. Biochemistry.2003,42(19):5555-5565.;Selwood T, et al. Arch Biochem Biophys. 2012,519(2):131-143.</Site_Reference>
      <Site_Type>Morpheein model</Site_Type>
      <PDB_ID>1NXG</PDB_ID>
      <PubMed_ID>12741811;22182754</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>2.3.3.1</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC2/3/3/1.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00710001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00710002</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00710003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00710004</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00710005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01720006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06128001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>